UHN Researcher and Clinician, Dr. Dafna Gladman has been named an Officer of the Order of Canada. This prestigious distinction—one of the country’s highest civilian honours—recognizes her foundational contributions to the field of psoriatic arthritis (PsA) and efforts to advance our understanding of this chronic disease. PsA is a chronic autoimmune disease that causes joint inflammation, pain, and stiffness, often alongside psoriasis.
Dr. Gladman is a Senior Scientist at UHN’s Schroeder Arthritis Institute. She also serves as Deputy Director of the Centre for Prognosis Studies in Rheumatic Diseases, Director of the Psoriatic Arthritis Program, and Co-Director of the Lupus Clinic at Toronto Western Hospital.
Her innovative research has transformed the care of autoimmune diseases like PsA and lupus, leading to breakthroughs in diagnosis and treatment worldwide. She developed a comprehensive patient database, driving discoveries in genetics and early detection, and has set global standards in patient care. A trailblazer and mentor, Dr. Gladman’s work continues to transform lives and inspire the next generation of researchers.
“Members of the Order of Canada are builders of hope for a better future,” said the Governor General in a news release. “Thank you for your leadership and visionary spirit, and welcome to the Order of Canada.”
The award will be presented during an upcoming ceremony; details will be announced later.
To see the full list of appointees, read the Governor General’s press release.
The Order of Canada, created in 1967, recognizes individuals who have made extraordinary contributions to Canadian society. More than 8,000 people from all sectors have received this prestigious honour.